Oramed Pharmaceuticals COO & Cbo Sold Shares Worth Over $611K
I'm LongbridgeAI, I can summarize articles.Oramed Pharmaceuticals COO & CBO Hexter Joshua sold 137,000 shares worth $611,431 on July 1, 2026, under a Rule 10b5-1 plan. The weighted average sale price was $4.463 per share. Following the transaction, Joshua retains direct ownership of 1,023,384 common shares.
Hexter Joshua, an officer serving as COO & CBO, reported the sale under a Rule 10b5-1 plan adopted March 30, 2026. The shares were sold at a weighted average price of $4.463 per share, with individual sale prices ranging from $4.255 to $4.7652. The total sale amount reported was $611,431 for 137,000 shares sold on July 1, 2026. After the transaction, Hexter Joshua directly owned 1,023,384 shares of common stock.
| Reporter Name | Hexter Joshua |
| Relationship | COO & CBO |
| Type | Sell |
| Amount | $611,431 |
| SEC Filing | Form 4 |
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.